Journal Information
Vol. 48. Issue S2.
Actualización en fibrosis pulmonar idiopática
Pages 7-12 (October 2012)
Share
Share
Download PDF
More article options
Vol. 48. Issue S2.
Actualización en fibrosis pulmonar idiopática
Pages 7-12 (October 2012)
Actualización en fibrosis pulmonar idiopática
Full text access
De la exclusión a la certidumbre. El recorrido hacia el diagnóstico de la fibrosis pulmonar idiopática
From exclusion to uncertainty: the route to diagnosing idiopathic pulmonary fibrosis
Visits
7029
Pedro J. Marcosa, Claudia Valenzuelab,c, Julio Ancocheab,c,
Corresponding author
julio.ancochea@uam.es

Autor para correspondencia.
a Servicio de Neumología, Complexo Hospitalario Universitario A Coruña, A Coruña, España
b Servicio de Neumología, Hospital Universitario de La Princesa, Madrid, España
c Instituto de Investigación Sanitaria Princesa (iP), Universidad Autónoma de Madrid, Madrid, España
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Resumen

La fibrosis pulmonar idiopática (FPI) es una enfermedad diferenciada dentro de las neumonías intersticiales idiopáticas. La FPI es progresiva y fibrosante, y está limitada a los pulmones. Afecta generalmente a adultos mayores de 50 años y se asocia con un patrón radiológico y/o histológico de neumonía intersticial usual. Clínicamente cursa con disnea de esfuerzo progresiva y tos seca. Se auscultan estertores crepitantes de predominio en bases en la mayoría de los pacientes y hay acropaquias en el 50%. No existen alteraciones analíticas específicas. El lavado broncoalveolar y la biopsia transbronquial no proporcionan el diagnóstico de fibrosis pulmonar idiopática, pero son útiles para descartar otras entidades. El diagnóstico definitivo requiere: a) la exclusión de otras entidades clínicas definidas o enfermedades pulmonares difusas de causa conocida, y b) la presencia de un patrón histológico de neumonía intersticial usual en el examen de tejido pulmonar obtenido mediante biopsia quirúrgica, la evidencia radiológica de patrón definido de neumonía intersticial usual en la tomografía computarizada de alta resolución, o ambos.

Palabras clave:
Fibrosis pulmonar idiopática
Neumonía intersticial usual
Diagnóstico radiológico e histológico
Abstract

Idiopathic pulmonary fibrosis (IPF) is a differentiated disease within the idiophatic interstitial pneumonias. IPF is progressive and fibrosing and is limited to the lungs. This entity generally affects persons older than 50 years old and is associated with the radiological and/or histological pattern of usual interstitial pneumonia (UIP). Clinically, IPF causes progressive exertional dyspnea and nonproductive cough. In most patients, physical examination reveals fine bibasilar inspiratory crackles and 50% of patients have digital clubbing. There are no specific laboratory alterations. Bronchoalveolar lavage and transbronchial biopsy will not establish the diagnosis of IPF but are useful to exclude other entities. Definitive diagnosis requires: a) exclusion of other, defined clinical entities or diffuse pulmonary diseases of known cause, and b) the presence of a histological pattern of UIP on analysis of pulmonary tissue from surgical biopsy, radiological evidence of the defined pattern of UIP on high-resolution computed tomography, or both.

Keywords:
Idiopathic pulmonary fibrosis
Usual interstitial pneumonia
Radiological and histological diagnosis
Full text is only aviable in PDF
Bibliografía
[1.]
American Thoracic Society/European Respiratory Society.
International multidisciplinary classification of the idiopathic interstitial pneumonias.
Am J Respir Crit Care Med, 165 (2002), pp. 277-304
[2.]
J. Ancochea, J. Gómez, J. Villar, A. Xaubet, on behalf of the SEPAR/SEICAT/SEAP Committee.
Consensus on the diagnosis of idiopathic interstitial pneumonia.
Arch Bronconeumol, 46 (2010), pp. 1-21
[3.]
G. Raghu, H.R. Collard, J.J. Egan, F.J. Martínez, J. Behr, K.K. Brown, et al.
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management.
Am J Resp Crit Care Med, 183 (2011), pp. 788-824
[4.]
J. Gribbin, R.B. Hubbard, I. Le Jeune, C.J.P. Smith, J. West, L.J. Tata.
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK.
Thorax, 61 (2006), pp. 980-985
[5.]
A. Xaubet, J. Ancochea, R. Blanquer, C. Montero, F. Morell, E. Rodríguez Becerra, et al.
Diagnóstico y tratamiento de las enfermedades pulmonares intersticiales difusas.
Arch Bronconeumol, 39 (2003), pp. 580-600
[6.]
A. Karakatsani, D. Papakosta, A. Rapti, K.M. Antoniou, M. Dimadi, A. Markopoulou, et al.
Epidemiology of interstitial lung diseases in Greece.
Resp Med, 103 (2009), pp. 1122-1129
[7.]
G. Raghu, D. Weycker, J. Edelsberg, W.Z. Bradford, G. Oster.
Incidence and prevalence of idiopathic pulmonary fibrosis.
Am J Resp Crit Care Med, 174 (2006), pp. 810-816
[8.]
E.R. Fernández Pérez, C.E. Daniels, D.R. Schroeder, J. St. Sauver, T.E. Hartman, B.J. Bartholmai, et al.
Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis a population-based study.
Chest, 137 (2010), pp. 129-137
[9.]
K.B. Baumgartner, J.M. Samet, C.A. Stidley, T.V. Colby, J.A. Waldron.
Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med, 155 (1997), pp. 242-248
[10.]
R. Hubbard, I. Johnston, D.B. Coultas, J. Britton.
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
Thorax, 51 (1996), pp. 711-716
[11.]
D.S. Kim, H.R. Collard, T.E. King Jr..
Classification and natural history of the idiopathic interstitial pneumonias.
Proc Am Thorac Soc, 3 (2006), pp. 285-292
[12.]
I.O. Rosas, T.J. Richards, K. Konishi, Y. Zhang, K. Gibson, A.E. Lokshin, et al.
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
PLoS Med, 29 (2008), pp. e93
[13.]
H. Ohnishi, A. Yokoyama, K. Kondo, H. Hamada, M. Abe, K. Nishimura, et al.
Comparative study of KL-6, surfactant protein-A, surfactantprotein-D, and monocyte chemoattractant protein-1 as serum markersfor interstitial lung diseases.
Am J Resp Crit Care Med, 165 (2002), pp. 378-381
[14.]
A. Moeller, S.E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, et al.
Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.
Am J Resp Crit Care Med, 179 (2009), pp. 588-594
[15.]
B. Van den Blink, M.S. Wijsenbeek, H.C. Hoogsteden.
Serum biomarkers in idiopathic pulmonary fibrosis.
Pulm Pharmacol Ther, 23 (2010), pp. 515-520
[16.]
U. Costabel, J. Guzman, F. Bonella, S. Oshimo.
Bronchoalveolar lavage in other interstitial lung diseases.
Semin Respir Crit Care Med, 28 (2007), pp. 514-524
[17.]
K.R. Flaherty, A.C. Andrei, T.E. King Jr., G. Raghu, T.V. Colby, A. Wells, et al.
Idiopathic interstitial pneumonia: Do community and academic physicians agree on diagnosis?.
Am J Respir Crit Care Med, 175 (2007), pp. 1054-1060
[18.]
S.R. Desai, S. Veeraraghavan, D.M. Hansell, A. Nikolakopolou, N.S. Goh, A.G. Nicholson, et al.
CT features of lung disease in patients with systemic scerosis: Comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
Radiology, 232 (2004), pp. 560-567
[19.]
B.W. Kinder, H.R. Collard, L. Koth, D.I. Daikh, P.J. Wolters, B. Elicker, et al.
Idiopathic nonspecific interstitial pneumonia: Lung manifestation of undifferentiated connective tissue disease?.
Am J Respir Crit Care Med, 176 (2007), pp. 691-697
[20.]
Global Initiative for Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2011). 2011.
[21.]
M. Thomeer, M. Demedts, J. Behr, R. Buhl, U. Costabel, C.D. Flower, et al.
Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis.
Eur Resp J, 31 (2008), pp. 585-591
[22.]
C. Beigelman-Aubry, C. Hill, A. Guibal, J. Savatovsky, P.A. Grenier.
Multi-detector row CT and postprocessing techniques in the assessment of diffuse lung disease.
Radiographics, 25 (2005), pp. 1639-1652
[23.]
H.F. Boehm, C. Fink, U. Attenberger, C. Becker, J. Behr, M. Reiser.
Automated classification of normal and pathologic pulmonary tissue by topological texture features extracted from multi-detector CT in 3D.
Eur Radiol, 18 (2008), pp. 2745-2755
[24.]
K. Marten, V. Dicken, C. Kneitz, M. Höhmann, W. Kenn, D. Hahn, et al.
Interstitial lung disease associated with collagen vascular disorders: disease quantification using a computer-aided diagnosis tool.
Eur Radiol, 19 (2009), pp. 324-332
[25.]
C.D. Fell, F.J. Martínez, L.X. Liu, S. Murray, M.K. Han, E.A. Kazerooni, et al.
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med, 181 (2010), pp. 832-837
[26.]
C.J. Zappala, P.I. Latsi, A.G. Nicholson, T.V. Colby, D. Cramer, E.A. Renzoni, et al.
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.
Eur Resp J, 35 (2010), pp. 830-836
Copyright © 2012. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?